Closing the Daily Disposable Gap in Presbyopic Astigmatism - Summary - MDSpire

Closing the Daily Disposable Gap in Presbyopic Astigmatism

New multifocal toric daily disposable lens highlights a broader shift in how the profession is approaching one of its most complex – and common – patient groups

  • February 17, 2026

  • 3 min

Share

Objective:

To address the challenge of managing patients with both astigmatism and presbyopia, focusing on improving comfort, convenience, and visual performance through the introduction of a new contact lens option.

Key Findings:
  • Astigmatism affects about half of patients in at least one eye, contributing to a significant need for effective management.
  • Presbyopia is projected to impact up to 2.1 billion people globally by 2030, highlighting the urgency for suitable solutions.
  • High dropout rates in contact lens wearers, with around one in four new wearers discontinuing use within the first year, are linked to dissatisfaction with vision quality and comfort.
  • 91% first-fit success rate reported for the new lens, indicating strong initial acceptance.
Interpretation:

The launch of this lens addresses a significant gap in the market for patients with both astigmatism and presbyopia, responding to clinician demands for better management options and improved patient satisfaction.

Limitations:
  • Clinical data will require further scrutiny as the lens enters wider use, particularly regarding long-term outcomes.
  • Initial availability is limited to select practices in the UK and Ireland, with a broader rollout planned for spring 2026.
Conclusion:

The ACUVUE® OASYS MAX 1-Day MULTIFOCAL for ASTIGMATISM represents a significant advancement in contact lens options for an underserved patient group, with potential to improve satisfaction and reduce dropout rates.

Original Source(s)

Closing the Daily Disposable Gap in Presbyopic Astigmatism

  • February 17, 2026

Related Content

GSLS 2026 Recap

A new venue provided the backdrop for another education-filled event.

Presbyopia as a Process: Why New Concepts Take Time

Presbyopia evolves over time; our treatment thinking should too

FDA Clears First Extended Depth of Focus Contact Lens for Presbyopia

Deseyne delivers smooth, continuous focus across near, intermediate, and distance vision, which is enabled by Cataltheia’s patented hyper-refractive central zone, engineered to precisely redirect light in a controlled manner.